EPO and hepatocellular carcinoma: Finally, three key genes were identified as prognostic markers for HCC patients via leave-one-out cross-validation method (EPO: Erythropoietin; BIRC5: Baculoviral IAP repeat-containing protein 5; SPP1: Secreted phosphoprotein 1).